Coronavirus (COVID-19) Collection
Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil
A significant number of patients recovering from COVID-19 report new, recurring, or persistent symptoms beyond 4 or more weeks after infection. These patients are referred to as experiencing “long COVID”, an umbrella term for the wide range of post-COVID-19 conditions (Centers for Disease Control and Prevention, 2021; Jennings et al., 2021).Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1
Risk factors have been described as associated with severe forms of COVID-19 (Zhang et al., 2020). Persons living with HIV-1 (PLWH1) often carry such comorbidities. As shown by Bhaskaran et al (2021), PLWH1 are at a greater risk of developing a severe form of COVID-19. Our objective was to determine the characteristics associated with the development of a severe or critical form of COVID-19 in a cohort of PLWH1 who were followed up at the Bichat-Claude Bernard University Hospital in Paris, France.Ethnicity and risk for SARS-CoV-2 infection among the healthcare workforce: Results of a retrospective cohort study in rural United Kingdom
To date, nearly 18 million confirmed cases of SARS-CoV-2 infection have been reported in the UK (World Health Organization, 2021). Because they are at the frontline of the outbreak, healthcare workers are particularly exposed to SARS-CoV-2 infection (Houlihan et al., 2020; Hunter et al., 2020). Despite supply of personal protective equipment and adoption of social distancing and shielding measures, healthcare staff continue to be more affected by COVID-19 than the general population (Nguyen et al., 2020; Office for National Statistics, 2021).Survival analysis of all critically ill patients with COVID-19 admitted to the main hospital in Mogadishu, Somalia, 30 March–12 June 2020: which interventions are proving effective in fragile states?
On 16 March 2020, the Federal Ministry of Health and Human Services of Somalia reported the country's first laboratory-confirmed case of coronavirus disease 2019 (COVID-19) in a Somali student arriving from China (WHO, 2020). By 31 October 2021, the country had officially reported 22,369 laboratory-confirmed cases of COVID-19, including 1238 associated deaths. Among the reported laboratory-confirmed COVID-19 cases, approximately 16% were admitted to isolation centres designated by the government (FMOH and WHO, 2021).Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study
Few studies have reported clinical COVID-19 sequelae six months (M6) after hospital discharge, but none has studied symptom severity.ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores
Coronavirus disease 2019 (COVID-19) is still the main global health, social and economic challenge, overwhelming healthcare systems in many countries and heavily burdening others (WHO 2020, Emanuel et al., 2020). Case rates continue to rise, and some hospitals are nearly at their full capacity of intensive care unit (ICU) beds. The emergence of new variants of SARS-CoV-2 in the UK, South Africa, Brazil and India is currently a cause of huge concern – with very high viral growth, being more transmissible, less detectable with the RT-PCR technique, or deadlier than the wild-type SARS-CoV-2, and with evidence of lower vaccine efficacy (Conti et al., 2121, Zhang, 2021, Faria et al., 2021, Rubin, 2021).SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
Infectious diseases have a profound impact on humans, particularly vulnerable populations (Fauci and Morens, 2012). The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and a lack of effective treatment and non-pharmaceutical interventions to curb transmission have led to an exponential increase in the burden of coronavirus disease 2019 (COVID-19) worldwide (Hsiang et al., 2020; Kraemer et al., 2020; Bo et al., 2021).Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the novel respiratory disease coronavirus disease-2019 (COVID-19) has been compared with seasonal Influenza. The equating of COVID-19 with another pandemic respiratory disease with similarities in symptoms, transmission, and risk groups is obvious at first, but it tempts to underestimate the impact of the current pandemic situation and to minimize COVID-19-related outcomes. Potentially, SARS-CoV-2 appears to cause higher morbidity and mortality rates than seasonal Influenza, also due to a lack of basic immunity in the population and lack of vaccination and medication (Petersen et al., 2020; RKI, 2020a, 2020b).
